SCHEMBL6581235

SCHEMBL6581235

CCc1c(N)cc(C)c2[nH]cnc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOS2 P35228 3/20 0.40
▸ NOS3 P29474 2/20 0.40
▸ ACP1 P24666 1/20 0.37
▸ PDPK1 O15530 1/20 0.33
▸ ADORA1 P30542 1/20 0.33
▸ PARP1 P09874 1/20 0.33
▸ NOS1 P29475 1/20 0.33
▸ MAPT P10636 2/20 0.32
▸ CDK1 P06493 4/20 0.32
▸ CCNB1 P14635 4/20 0.32
▸ CCNA2 P20248 4/20 0.32
▸ CDK2 P24941 4/20 0.32
▸ CCNA1 P78396 4/20 0.32
▸ CSNK2A2 P19784 2/20 0.32
▸ CSNK2A1 P68400 2/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ CSNK2B P67870 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ DYRK1A Q13627 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6581243 0.87 NOS3 (0.36) NOS2NOS3ACP1PDPK1PARP1
SCHEMBL6142564 0.79 PDPK1 (0.37) PDPK1PARP1MAPTCSNK2A2CSNK2A1
SCHEMBL15629821 0.77 NOS3 (0.40) NOS2NOS3PDPK1ADORA1PARP1
SCHEMBL7033872 0.76 MEN1 (0.50) PDPK1PARP1MAPTCSNK2A2CSNK2A1
SCHEMBL6581428 0.73 ALDH1A1 (0.32) ALDH1A1
SCHEMBL6581839 0.73 PDPK1 (0.32) PDPK1PARP1
SCHEMBL6142566 0.72 PARP1 (0.40) PDPK1PARP1MAPTCSNK2A2CSNK2A1
SCHEMBL16091767 0.71 NOS2 (0.36) NOS2NOS3PDPK1ADORA1PARP1
SCHEMBL6876629 0.71 PARP1 (0.42) ACP1PDPK1PARP1CSNK2A2CSNK2A1
SCHEMBL6580990 0.70 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1037887-B1 5-(2-IMIDAZOLINYLAMINO)-BENZIMIDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS .ALPHA.-ADRENOCEPTOR AGONISTS WITH IMPROVED METABOLIC STABILITY PROCTER & GAMBLE (US) 2004-07-14 — — EP disclosed
US-6486190-B1 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as .alpha.-adrenoceptor agonists with improved metabolic stability THE PROCTER & GAMBLE COMPANY 2002-11-26 — — US disclosed
EP-1037887-A1 5-(2-IMIDAZOLINYLAMINO)-BENZIMIDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS .ALPHA.-ADRENOCEPTOR AGONISTS WITH IMPROVED METABOLIC STABILITY THE PROCTER & GAMBLE COMPANY (US) 2000-09-27 — — EP disclosed
WO-1999026942-A1 5-(2-IMIDAZOLINYLAMINO)-BENZIMIDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS .ALPHA.-ADRENOCEPTOR AGONISTS WITH IMPROVED METABOLIC STABILITY THE PROCTER & GAMBLE COMPANY (US) 1999-06-03 — — WO disclosed
Send feedback